PTEN and Familial prostate cancer: The prostate cancer-related TFA signatures can be used to classify PTEN status in human prostate cancers to a similar accuracy as the PTEN-controlled TFAs, but they had less cross-tissue predictive power as they failed to reach significance levels when applied to breast and brain tumors (Figure 5B, blue bars).